Page last updated: 2024-09-02

tadalafil and Cardio-Renal Syndrome

tadalafil has been researched along with Cardio-Renal Syndrome in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Abassi, Z; Abu-Saleh, N; Armaly, Z; Aronson, D; Assady, S; Awad, H; Bishara, B; Ghrayeb, N; Goltsman, I; Haddad, E; Haddad, S; Khamaysi, I	1

Other Studies

1 other study(ies) available for tadalafil and Cardio-Renal Syndrome

Article	Year
Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure. European journal of heart failure, 2012, Volume: 14, Issue:10 Topics: Animals; Carbolines; Cardio-Renal Syndrome; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Intra-Abdominal Hypertension; Kidney; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renal Plasma Flow; Tadalafil	2012

Article

Year

Phosphodiesterase 5 inhibition protects against increased intra-abdominal pressure-induced renal dysfunction in experimental congestive heart failure.

European journal of heart failure, 2012, Volume: 14, Issue:10

Topics: Animals; Carbolines; Cardio-Renal Syndrome; Disease Models, Animal; Glomerular Filtration Rate; Heart Failure; Hemodynamics; Intra-Abdominal Hypertension; Kidney; Male; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renal Plasma Flow; Tadalafil

2012